Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 8.23K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -2.04M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -99.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -100.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | 0.62 | Shares Outstanding | 41.13M | 52W Low Chg | - |
| Insider Own | 10.16% | ROA | -126.04% | Shares Float | 36.95M | Beta | 1.51 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00020 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 230 | Target Price | - |
| Oper. Margin | - | Earnings Date | Jun 25 | Volume | 14,313 | Change | 0.00% |
About ADVANCED PROTEOME THERAPEUTICS
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.